Boston team secures $9M grant for molecular neuroimaging study of aging brain

Boston researchers will co-lead a long-term molecular neuroimaging study examining brain aging and vulnerability to cognitive decline, backed by a $9M grant. Specific imaging modalities, enrollment targets, and timelines not yet reported.

• Grant-funded prospective study focused on identifying neuroimaging biomarkers of aging-related neural injury and cognitive decline; full study design details not disclosed in source.
• No primary outcome data available — this is a funding announcement, not a completed study.
• Key unknowns include enrollment size, specific molecular imaging tracers or modalities, duration, and sponsoring agency — limiting assessment of scientific scope.

RadPigeon summaries are original and for information only. They are not clinical advice.